UK Guide · Updated July 2026 · Reviewed by our superintendent pharmacist
Wegovy now comes as a once-daily tablet or a once-weekly injection. Same active ingredient, very different routines. Here's how a pharmacist helps you choose.
The short answer
Both deliver similar weight loss (roughly 15–17% of body weight in trials) because both are semaglutide. Choose the pill if you dislike needles, travel often, or prefer a daily habit — but you must take it on an empty stomach and wait 30 minutes before breakfast. Choose the injection if you'd rather think about treatment once a week, want no food-timing rules, or may later need the new 7.2 mg high dose (up to 20.7% weight loss in trials). At our Timperley pharmacy the pill's maintenance dose is £199/month vs £225/month for the 2.4 mg injection, and switching between them is straightforward when planned by a pharmacist.
In June 2026 the MHRA approved the Wegovy pill (oral semaglutide) — the UK's first daily GLP-1 tablet for weight loss — and it's now in stock alongside the familiar Wegovy injection at pharmacies like ours. Both contain semaglutide, a GLP-1 receptor agonist that reduces hunger, quietens food noise and helps you feel full sooner. Both are licensed for adults with a BMI of 30+, or 27+ with a weight-related condition, alongside diet and activity changes.
So the real question isn't "which drug is better?" — it's "which delivery method will you actually stick with for a year or more?" That's what determines results.
| Feature | Wegovy Pill | Wegovy Injection |
|---|---|---|
| How it’s taken | Tablet, swallowed whole | Pre-filled pen, self-injected |
| Frequency | Once daily, every morning | Once weekly, any time of day |
| Food rules | Empty stomach + 30-min wait | None |
| Doses | 1.5 → 4 → 9 → 25 mg | 0.25 → 0.5 → 1 → 1.7 → 2.4 mg (+ new 7.2 mg high dose) |
| Trial weight loss | ~17% over 64 weeks (OASIS 4) | ~15–17.5% (2.4 mg) · 20.7% (7.2 mg, STEP UP) |
| Storage | Room temperature | Fridge before first use |
| Needles | None | One tiny needle weekly |
| Price at WeightGone UK | £100–£199/month | £100–£225/month (7.2 mg: £250 offer) |
The pill's biggest hidden cost is the morning routine. It only absorbs properly on an empty stomach: take it when you wake, with a sip of water, then nothing to eat or drink — including tea, coffee and other medicines — for at least 30 minutes. If your mornings are chaotic, you do shift work, or you take other early-morning medication (thyroid tablets are a classic clash), that rule gets old fast.
The injection asks for courage once a week and nothing more. No food rules, any time of day, and modern pens use a needle most people describe as barely noticeable. In our experience at the pharmacy, needle anxiety fades within two or three doses — but a daily 30-minute fasting window either fits your life or it doesn't.
There is no head-to-head trial of the pill against the injection, so honest comparisons quote each medicine's own studies. The 25 mg daily tablet produced ~17% average weight loss over 64 weeks in people who stayed on treatment (OASIS 4). The 2.4 mg weekly injection produced ~15–17.5% over 68–72 weeks in its trials — and the new 7.2 mg high dose reached 20.7%, with a third of participants losing 25% or more (STEP UP).
Two practical takeaways: for standard doses, the difference is too small to base your choice on — adherence matters far more. But if you have a lot of weight to lose and want the highest-ceiling semaglutide option, only the injection currently goes up to 7.2 mg.
Private prices vary between providers, so compare like-for-like: at WeightGone UK both forms start at £100/month, and at full maintenance dose the pill is £199/month versus £225/month for the 2.4 mg injection — with the 7.2 mg high dose at a £250/month launch offer. Every price includes a face-to-face review each month; be wary of headline prices elsewhere that quote the starting dose only, or charge extra for follow-up.
See live pricing on our Wegovy pill, Wegovy injection and treatments pages.
This decision isn't permanent. The licensed guidance allows a direct switch from the 2.4 mg weekly injection to the 25 mg daily pill with no re-titration, and moves in the other direction are routinely planned too. What matters is timing — a weekly and a daily medicine overlap differently, so switching without a plan risks either a treatment gap or a doubled-up dose. At WeightGone UK every switch is planned face-to-face; read more in our switching guide.
WeightGone UK is a GPhC-registered pharmacy (reg. 1118728) in Timperley, Altrincham, serving Sale, Hale, Stretford, Wythenshawe and the wider Greater Manchester area. Unlike online-only providers, every patient is assessed face-to-face, weighed on the same scales each month, and reviewed in person by the same pharmacist — whichever form of Wegovy you choose, and whether you stay on it or switch.
Sources
Published 6 July 2026. Written and clinically reviewed by the WeightGone UK pharmacy team. This article is information, not a prescription — suitability is always confirmed face-to-face.
They're broadly comparable. In separate trials, the 25 mg daily pill produced around 17% average weight loss over 64 weeks (OASIS 4, on treatment), while the 2.4 mg weekly injection produced around 15–17.5% over 68–72 weeks. There's no head-to-head trial, and the injection now also has a 7.2 mg high dose that reached 20.7%. For most people the deciding factor is routine, not effectiveness.
At WeightGone UK both start at £100/month at the first dose level. At maintenance, the 25 mg pill is £199/month versus £225/month for the 2.4 mg injection — so the pill is slightly cheaper at our pharmacy. The new 7.2 mg high-dose injection is £250/month on our current launch offer. All prices include monthly face-to-face pharmacist reviews.
Yes. Under the MHRA-approved guidance, people established on the 2.4 mg weekly injection can transition directly to the 25 mg daily tablet without re-titrating. On a lower injection dose, your pharmacist maps you to the closest tablet step. The switch should always be planned face-to-face so there's no gap or double-dosing.
Largely yes — both contain semaglutide, so the common side effects are gastrointestinal: nausea, constipation, diarrhoea and reduced appetite, usually mild to moderate and settling as your body adjusts. Both are titrated gradually to keep this manageable, and monthly reviews catch problems early.
Semaglutide is a peptide that stomach acid and food interfere with. The tablet only absorbs properly if you take it first thing in the morning on an empty stomach, with just a sip of water, then wait at least 30 minutes before eating, drinking or taking other oral medicines. If that routine doesn't fit your life, the weekly injection has no food rules at all.
The pill usually wins for travel: tablets store at room temperature, while injection pens need refrigeration before first use and careful handling in hot weather. There are no needles to carry through airport security either. Frequent flyers are one of the groups we most often switch to the tablet.
The 2.4 mg injection is available on the NHS for some people via specialist weight-management services, usually with strict criteria and long waits. The pill and the 7.2 mg high-dose injection are private-only for now while NICE evaluations are pending. As a private pharmacy in Timperley we can usually assess and start eligible patients within days.
Neither form is suitable in pregnancy or breastfeeding, with a history of pancreatitis, with a personal or family history of medullary thyroid cancer or MEN 2, or alongside another GLP-1 medicine. This isn't a complete list — suitability is always confirmed at a face-to-face assessment with our GPhC-registered pharmacist.
Medically reviewed by Muhammad Adnan, GPhC-registered Superintendent Pharmacist · Last updated June 2026.
This article is general information and isn't a substitute for personal medical advice. Your pharmacist will assess what's right for you at a face-to-face consultation. More health advice · Book a consultation.
WeightGone